Trial intelligence / Profile preview

Vanos Cream in Atopic Dermatitis

NCT00819507Phase 4Completed

Sponsor
Oregon Health & Science University
Start
Jan 2009
Primary completion
Jan 2010
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of fluocinonide in atopic dermatitis (AD), sponsored by Oregon Health & Science University. Started Jan 2009; status: completed.

02

Drugs

fluocinonide
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on NCT00819507.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00819507.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call